| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Hepatitis E virus | 51 | 2024 | 72 | 16.460 |
Why?
|
| Hepatitis E | 44 | 2024 | 76 | 15.640 |
Why?
|
| Antibodies, Neutralizing | 89 | 2025 | 2006 | 13.770 |
Why?
|
| Antibodies, Viral | 109 | 2025 | 3211 | 13.480 |
Why?
|
| Hepatitis B virus | 45 | 2024 | 527 | 10.330 |
Why?
|
| Capsid Proteins | 39 | 2025 | 468 | 8.360 |
Why?
|
| Neutralization Tests | 35 | 2024 | 739 | 7.560 |
Why?
|
| Hepatitis B, Chronic | 22 | 2024 | 410 | 7.340 |
Why?
|
| Enterovirus A, Human | 17 | 2024 | 27 | 7.030 |
Why?
|
| Papillomavirus Vaccines | 25 | 2025 | 497 | 6.710 |
Why?
|
| Epitopes | 55 | 2023 | 2525 | 6.520 |
Why?
|
| Hand, Foot and Mouth Disease | 14 | 2021 | 25 | 6.100 |
Why?
|
| Enterovirus | 15 | 2024 | 69 | 6.060 |
Why?
|
| Viral Vaccines | 19 | 2022 | 596 | 5.380 |
Why?
|
| Papillomavirus Infections | 28 | 2025 | 1640 | 5.260 |
Why?
|
| Viral Hepatitis Vaccines | 15 | 2024 | 72 | 5.160 |
Why?
|
| Hepatitis Antibodies | 20 | 2023 | 67 | 4.910 |
Why?
|
| Antibodies, Monoclonal | 58 | 2024 | 9261 | 4.730 |
Why?
|
| Vaccines, Virus-Like Particle | 19 | 2025 | 44 | 4.630 |
Why?
|
| Herpesvirus 3, Human | 14 | 2024 | 159 | 4.560 |
Why?
|
| Hepatitis B Surface Antigens | 18 | 2024 | 294 | 4.300 |
Why?
|
| Rotavirus Infections | 8 | 2024 | 85 | 4.300 |
Why?
|
| Vaccines, Synthetic | 21 | 2022 | 622 | 4.180 |
Why?
|
| Viral Envelope Proteins | 19 | 2024 | 641 | 4.020 |
Why?
|
| Hepatitis B Antibodies | 14 | 2024 | 155 | 3.900 |
Why?
|
| Hepatitis B | 20 | 2024 | 707 | 3.760 |
Why?
|
| Papillomaviridae | 16 | 2025 | 1140 | 3.670 |
Why?
|
| Influenza A Virus, H5N1 Subtype | 11 | 2022 | 115 | 3.590 |
Why?
|
| Rotavirus Vaccines | 6 | 2024 | 62 | 3.460 |
Why?
|
| Mice, Inbred BALB C | 53 | 2025 | 6228 | 3.410 |
Why?
|
| Viral Proteins | 26 | 2023 | 1802 | 3.370 |
Why?
|
| Respiratory Syncytial Virus, Human | 6 | 2024 | 149 | 3.230 |
Why?
|
| Rotavirus | 6 | 2024 | 110 | 3.180 |
Why?
|
| Human papillomavirus 16 | 11 | 2023 | 268 | 3.050 |
Why?
|
| Enterovirus Infections | 7 | 2024 | 74 | 3.010 |
Why?
|
| Human papillomavirus 18 | 10 | 2024 | 125 | 2.940 |
Why?
|
| Antigens, Viral | 16 | 2024 | 992 | 2.830 |
Why?
|
| Influenza B virus | 5 | 2022 | 53 | 2.800 |
Why?
|
| Chickenpox | 5 | 2023 | 96 | 2.770 |
Why?
|
| Oncolytic Viruses | 6 | 2024 | 345 | 2.750 |
Why?
|
| RNA, Viral | 26 | 2023 | 2866 | 2.750 |
Why?
|
| Antiviral Agents | 23 | 2023 | 3064 | 2.720 |
Why?
|
| Coxsackievirus Infections | 6 | 2023 | 45 | 2.690 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 34 | 2023 | 3811 | 2.690 |
Why?
|
| Respiratory Syncytial Virus Infections | 6 | 2024 | 365 | 2.660 |
Why?
|
| Oncolytic Virotherapy | 5 | 2024 | 521 | 2.640 |
Why?
|
| Herpesvirus 1, Suid | 4 | 2024 | 25 | 2.630 |
Why?
|
| DNA, Viral | 19 | 2023 | 2205 | 2.520 |
Why?
|
| Virus Replication | 19 | 2022 | 2458 | 2.490 |
Why?
|
| Escherichia coli | 31 | 2025 | 4209 | 2.470 |
Why?
|
| Cryoelectron Microscopy | 16 | 2024 | 647 | 2.470 |
Why?
|
| Influenza, Human | 9 | 2023 | 1539 | 2.430 |
Why?
|
| Influenza Vaccines | 8 | 2023 | 780 | 2.350 |
Why?
|
| Animals | 181 | 2025 | 169322 | 2.260 |
Why?
|
| Enzyme-Linked Immunospot Assay | 7 | 2022 | 126 | 2.220 |
Why?
|
| Oncogene Proteins, Viral | 7 | 2019 | 342 | 2.210 |
Why?
|
| Virion | 17 | 2024 | 430 | 2.210 |
Why?
|
| Capsid | 12 | 2022 | 435 | 2.170 |
Why?
|
| Hemagglutinin Glycoproteins, Influenza Virus | 6 | 2022 | 161 | 2.130 |
Why?
|
| Mice | 121 | 2025 | 82004 | 2.130 |
Why?
|
| Immunoglobulin M | 13 | 2023 | 1528 | 2.020 |
Why?
|
| Disease Models, Animal | 31 | 2024 | 18358 | 2.010 |
Why?
|
| High-Throughput Screening Assays | 9 | 2021 | 937 | 1.970 |
Why?
|
| Hepatitis B Core Antigens | 12 | 2021 | 90 | 1.970 |
Why?
|
| HIV Antibodies | 8 | 2022 | 1341 | 1.940 |
Why?
|
| China | 28 | 2023 | 2389 | 1.940 |
Why?
|
| Epitope Mapping | 7 | 2018 | 300 | 1.830 |
Why?
|
| Orthomyxoviridae Infections | 5 | 2022 | 255 | 1.770 |
Why?
|
| Recombinant Proteins | 27 | 2022 | 6512 | 1.690 |
Why?
|
| Vaccines, Attenuated | 7 | 2024 | 314 | 1.670 |
Why?
|
| Hepatitis B e Antigens | 5 | 2021 | 135 | 1.600 |
Why?
|
| Adjuvants, Immunologic | 13 | 2024 | 998 | 1.560 |
Why?
|
| Vaccines | 5 | 2023 | 842 | 1.540 |
Why?
|
| Epstein-Barr Virus Infections | 6 | 2023 | 617 | 1.500 |
Why?
|
| Epitopes, B-Lymphocyte | 3 | 2019 | 85 | 1.480 |
Why?
|
| Herpes Zoster Vaccine | 3 | 2023 | 49 | 1.480 |
Why?
|
| Cricetinae | 11 | 2024 | 2423 | 1.470 |
Why?
|
| Macaca fascicularis | 6 | 2024 | 913 | 1.470 |
Why?
|
| Communicable Diseases, Emerging | 2 | 2023 | 148 | 1.470 |
Why?
|
| Hep G2 Cells | 16 | 2024 | 375 | 1.460 |
Why?
|
| Herpes Zoster | 4 | 2023 | 252 | 1.450 |
Why?
|
| Influenza A virus | 5 | 2019 | 460 | 1.440 |
Why?
|
| Humans | 273 | 2025 | 768298 | 1.440 |
Why?
|
| Hepatocytes | 9 | 2019 | 1245 | 1.430 |
Why?
|
| Hepatitis B Vaccines | 6 | 2024 | 178 | 1.420 |
Why?
|
| Vaccination | 17 | 2024 | 3431 | 1.420 |
Why?
|
| Viral Structural Proteins | 3 | 2019 | 93 | 1.420 |
Why?
|
| Uterine Cervical Neoplasms | 9 | 2022 | 2044 | 1.400 |
Why?
|
| Clinical Laboratory Techniques | 4 | 2020 | 749 | 1.400 |
Why?
|
| Immunoglobulin A | 7 | 2023 | 991 | 1.380 |
Why?
|
| Orthomyxoviridae | 2 | 2022 | 148 | 1.380 |
Why?
|
| Coronavirus Infections | 9 | 2020 | 3118 | 1.370 |
Why?
|
| Human papillomavirus 6 | 4 | 2023 | 16 | 1.340 |
Why?
|
| Genotype | 29 | 2024 | 13038 | 1.320 |
Why?
|
| Pichia | 5 | 2016 | 49 | 1.320 |
Why?
|
| Herpesvirus 1, Human | 4 | 2022 | 744 | 1.310 |
Why?
|
| Nucleocapsid Proteins | 8 | 2015 | 75 | 1.290 |
Why?
|
| Pneumonia, Viral | 7 | 2020 | 3241 | 1.280 |
Why?
|
| Single-Chain Antibodies | 3 | 2020 | 114 | 1.270 |
Why?
|
| Immunoglobulin G | 19 | 2022 | 4570 | 1.260 |
Why?
|
| Pandemics | 13 | 2023 | 8750 | 1.250 |
Why?
|
| Receptors, Virus | 6 | 2021 | 648 | 1.240 |
Why?
|
| Cross Protection | 3 | 2024 | 25 | 1.200 |
Why?
|
| HIV-1 | 9 | 2022 | 6963 | 1.200 |
Why?
|
| Herpesvirus 4, Human | 7 | 2023 | 1082 | 1.170 |
Why?
|
| Interferon-alpha | 3 | 2022 | 910 | 1.170 |
Why?
|
| Phylogeny | 12 | 2022 | 2842 | 1.170 |
Why?
|
| Immunoglobulins | 2 | 2023 | 855 | 1.160 |
Why?
|
| env Gene Products, Human Immunodeficiency Virus | 3 | 2019 | 381 | 1.150 |
Why?
|
| Blood Donors | 5 | 2021 | 344 | 1.130 |
Why?
|
| Bacteriophages | 4 | 2024 | 382 | 1.120 |
Why?
|
| gag Gene Products, Human Immunodeficiency Virus | 2 | 2018 | 215 | 1.120 |
Why?
|
| Cell Line | 28 | 2024 | 15593 | 1.120 |
Why?
|
| Gene Expression | 9 | 2022 | 7595 | 1.110 |
Why?
|
| Viral Nonstructural Proteins | 3 | 2024 | 228 | 1.110 |
Why?
|
| Peptide Library | 7 | 2015 | 350 | 1.110 |
Why?
|
| Immunoassay | 6 | 2022 | 744 | 1.100 |
Why?
|
| Immunization, Passive | 4 | 2022 | 619 | 1.090 |
Why?
|
| Antigen-Antibody Complex | 2 | 2018 | 513 | 1.060 |
Why?
|
| Recombinant Fusion Proteins | 8 | 2019 | 3728 | 1.050 |
Why?
|
| Mutagenesis | 4 | 2017 | 1229 | 1.040 |
Why?
|
| Seroepidemiologic Studies | 7 | 2019 | 405 | 1.040 |
Why?
|
| Mesocricetus | 6 | 2024 | 256 | 1.040 |
Why?
|
| Antibody Formation | 4 | 2020 | 1393 | 1.010 |
Why?
|
| Cytomegalovirus Infections | 2 | 2022 | 839 | 0.960 |
Why?
|
| Cytomegalovirus | 4 | 2022 | 754 | 0.950 |
Why?
|
| Biosensing Techniques | 3 | 2022 | 661 | 0.950 |
Why?
|
| Human papillomavirus 11 | 2 | 2017 | 14 | 0.950 |
Why?
|
| Antigens | 7 | 2024 | 1443 | 0.940 |
Why?
|
| Baculoviridae | 6 | 2022 | 115 | 0.940 |
Why?
|
| Hepatitis Antigens | 4 | 2019 | 8 | 0.920 |
Why?
|
| Communicable Diseases | 2 | 2023 | 873 | 0.920 |
Why?
|
| Manganese | 2 | 2024 | 394 | 0.920 |
Why?
|
| RNA-Binding Proteins | 5 | 2016 | 1883 | 0.920 |
Why?
|
| Luminescent Measurements | 5 | 2021 | 343 | 0.900 |
Why?
|
| Green Fluorescent Proteins | 7 | 2015 | 2068 | 0.890 |
Why?
|
| Caudovirales | 1 | 2023 | 3 | 0.890 |
Why?
|
| Enterovirus B, Human | 4 | 2023 | 49 | 0.880 |
Why?
|
| Polymerase Chain Reaction | 6 | 2021 | 6084 | 0.880 |
Why?
|
| Binding Sites | 8 | 2024 | 6018 | 0.880 |
Why?
|
| Chromatography, Affinity | 3 | 2016 | 525 | 0.870 |
Why?
|
| Serum Albumin | 2 | 2018 | 676 | 0.870 |
Why?
|
| Respiratory Syncytial Virus Vaccines | 2 | 2024 | 37 | 0.860 |
Why?
|
| Lung | 8 | 2022 | 10087 | 0.850 |
Why?
|
| Immunoglobulin Fragments | 3 | 2011 | 84 | 0.830 |
Why?
|
| Reassortant Viruses | 2 | 2020 | 36 | 0.830 |
Why?
|
| Immunoenzyme Techniques | 2 | 2015 | 1705 | 0.820 |
Why?
|
| Superinfection | 1 | 2022 | 63 | 0.810 |
Why?
|
| Escherichia coli Vaccines | 1 | 2022 | 10 | 0.810 |
Why?
|
| Influenza A Virus, H1N1 Subtype | 3 | 2022 | 450 | 0.800 |
Why?
|
| Chickenpox Vaccine | 1 | 2022 | 40 | 0.790 |
Why?
|
| Trans-Activators | 4 | 2021 | 2855 | 0.790 |
Why?
|
| Peptides | 5 | 2022 | 4352 | 0.790 |
Why?
|
| Influenza in Birds | 4 | 2010 | 76 | 0.780 |
Why?
|
| Cancer Vaccines | 4 | 2024 | 1042 | 0.780 |
Why?
|
| Cell-Penetrating Peptides | 2 | 2021 | 43 | 0.780 |
Why?
|
| Nanoparticles | 5 | 2024 | 1986 | 0.760 |
Why?
|
| Immunotherapy | 10 | 2024 | 4740 | 0.760 |
Why?
|
| Viral Fusion Proteins | 2 | 2022 | 100 | 0.750 |
Why?
|
| Pseudorabies | 1 | 2021 | 6 | 0.750 |
Why?
|
| Immunization | 9 | 2023 | 1219 | 0.750 |
Why?
|
| Antibodies, Monoclonal, Murine-Derived | 5 | 2019 | 695 | 0.740 |
Why?
|
| Coronaviridae Infections | 1 | 2020 | 10 | 0.740 |
Why?
|
| Models, Molecular | 14 | 2024 | 5408 | 0.740 |
Why?
|
| Nucleic Acids | 1 | 2023 | 189 | 0.730 |
Why?
|
| Protein Phosphatase 1 | 1 | 2021 | 135 | 0.730 |
Why?
|
| Antibody-Dependent Cell Cytotoxicity | 1 | 2022 | 306 | 0.730 |
Why?
|
| Antibody Specificity | 8 | 2020 | 1065 | 0.730 |
Why?
|
| Virus Internalization | 4 | 2019 | 503 | 0.730 |
Why?
|
| Guanine | 1 | 2022 | 280 | 0.720 |
Why?
|
| Food Analysis | 1 | 2021 | 103 | 0.720 |
Why?
|
| Virus Attachment | 2 | 2019 | 57 | 0.720 |
Why?
|
| Nasopharyngeal Neoplasms | 2 | 2023 | 290 | 0.710 |
Why?
|
| Vaccines, Subunit | 5 | 2024 | 159 | 0.700 |
Why?
|
| Antibodies | 5 | 2022 | 2425 | 0.690 |
Why?
|
| Cytidine Deaminase | 1 | 2022 | 243 | 0.690 |
Why?
|
| Alphapapillomavirus | 3 | 2022 | 218 | 0.680 |
Why?
|
| Nucleosides | 2 | 2017 | 131 | 0.680 |
Why?
|
| Liver Cirrhosis | 3 | 2022 | 1957 | 0.680 |
Why?
|
| Hepatitis Delta Virus | 2 | 2017 | 24 | 0.680 |
Why?
|
| Molecular Epidemiology | 2 | 2019 | 472 | 0.680 |
Why?
|
| Hepatitis D | 2 | 2017 | 23 | 0.670 |
Why?
|
| Microfluidics | 2 | 2023 | 674 | 0.670 |
Why?
|
| Liver Failure, Acute | 1 | 2021 | 182 | 0.670 |
Why?
|
| Nucleoproteins | 1 | 2019 | 110 | 0.660 |
Why?
|
| Neurotoxicity Syndromes | 1 | 2023 | 302 | 0.660 |
Why?
|
| Immunologic Deficiency Syndromes | 1 | 2023 | 549 | 0.660 |
Why?
|
| Genome, Viral | 5 | 2023 | 673 | 0.660 |
Why?
|
| Carcinoma, Hepatocellular | 5 | 2022 | 2331 | 0.650 |
Why?
|
| Primates | 1 | 2021 | 521 | 0.640 |
Why?
|
| Porins | 1 | 2019 | 78 | 0.640 |
Why?
|
| Genetic Vectors | 10 | 2019 | 3411 | 0.630 |
Why?
|
| Female | 85 | 2025 | 397050 | 0.630 |
Why?
|
| Sensitivity and Specificity | 18 | 2020 | 14736 | 0.630 |
Why?
|
| Drug Evaluation, Preclinical | 3 | 2020 | 1339 | 0.620 |
Why?
|
| Technology, Pharmaceutical | 3 | 2015 | 84 | 0.620 |
Why?
|
| Diphtheria Toxin | 1 | 2019 | 253 | 0.620 |
Why?
|
| Macaca mulatta | 10 | 2024 | 2361 | 0.610 |
Why?
|
| Lung Injury | 2 | 2022 | 433 | 0.610 |
Why?
|
| Gastroenteritis | 1 | 2020 | 236 | 0.610 |
Why?
|
| Viremia | 2 | 2018 | 725 | 0.600 |
Why?
|
| Globulins | 1 | 2018 | 19 | 0.600 |
Why?
|
| Protein Binding | 16 | 2024 | 9346 | 0.600 |
Why?
|
| DNA Primers | 2 | 2020 | 2823 | 0.600 |
Why?
|
| Rabbits | 6 | 2024 | 4782 | 0.600 |
Why?
|
| Cell Line, Tumor | 19 | 2024 | 17132 | 0.600 |
Why?
|
| DNA, Circular | 2 | 2017 | 97 | 0.600 |
Why?
|
| Vaccines, Combined | 4 | 2022 | 70 | 0.590 |
Why?
|
| Plasmids | 7 | 2021 | 2267 | 0.590 |
Why?
|
| Immunologic Tests | 2 | 2017 | 104 | 0.590 |
Why?
|
| Diarrhea | 3 | 2020 | 1320 | 0.590 |
Why?
|
| Mesenchymal Stem Cell Transplantation | 2 | 2023 | 507 | 0.580 |
Why?
|
| Neuroprotective Agents | 2 | 2024 | 957 | 0.580 |
Why?
|
| Respiratory Mucosa | 1 | 2021 | 439 | 0.580 |
Why?
|
| Peptide Fragments | 4 | 2019 | 5151 | 0.580 |
Why?
|
| Warts | 1 | 2017 | 66 | 0.580 |
Why?
|
| Mice, SCID | 7 | 2023 | 2632 | 0.580 |
Why?
|
| Condylomata Acuminata | 1 | 2017 | 79 | 0.580 |
Why?
|
| Human papillomavirus 31 | 1 | 2017 | 1 | 0.580 |
Why?
|
| Serum | 1 | 2019 | 207 | 0.580 |
Why?
|
| Progesterone | 1 | 2022 | 751 | 0.570 |
Why?
|
| Immunologic Surveillance | 1 | 2018 | 93 | 0.570 |
Why?
|
| HIV Antigens | 1 | 2018 | 328 | 0.570 |
Why?
|
| Microfluidic Analytical Techniques | 1 | 2023 | 823 | 0.560 |
Why?
|
| Chimera | 1 | 2018 | 454 | 0.560 |
Why?
|
| Drug Carriers | 2 | 2019 | 710 | 0.560 |
Why?
|
| Herpes Simplex | 2 | 2022 | 470 | 0.560 |
Why?
|
| Serotyping | 1 | 2017 | 332 | 0.560 |
Why?
|
| Liver Failure | 1 | 2019 | 252 | 0.550 |
Why?
|
| HIV Envelope Protein gp120 | 2 | 2018 | 925 | 0.550 |
Why?
|
| CD8-Positive T-Lymphocytes | 6 | 2024 | 4647 | 0.550 |
Why?
|
| Viral Core Proteins | 2 | 2014 | 157 | 0.540 |
Why?
|
| Codon, Terminator | 1 | 2017 | 125 | 0.540 |
Why?
|
| Hydrophobic and Hydrophilic Interactions | 6 | 2019 | 395 | 0.530 |
Why?
|
| Protein Phosphatase 2 | 1 | 2018 | 231 | 0.530 |
Why?
|
| Respiratory Syncytial Viruses | 1 | 2017 | 168 | 0.530 |
Why?
|
| Transcriptional Activation | 2 | 2019 | 1748 | 0.530 |
Why?
|
| Receptors, Immunologic | 2 | 2020 | 1416 | 0.530 |
Why?
|
| Tupaia | 1 | 2015 | 1 | 0.530 |
Why?
|
| Amino Acids | 3 | 2023 | 1716 | 0.530 |
Why?
|
| Donor Selection | 1 | 2018 | 240 | 0.520 |
Why?
|
| Protein Conformation | 10 | 2024 | 3957 | 0.520 |
Why?
|
| Viral Regulatory and Accessory Proteins | 4 | 2021 | 148 | 0.520 |
Why?
|
| Ribonucleoproteins | 2 | 2018 | 359 | 0.520 |
Why?
|
| Evolution, Molecular | 3 | 2022 | 1893 | 0.520 |
Why?
|
| Liver Neoplasms | 5 | 2022 | 4360 | 0.510 |
Why?
|
| Transposases | 1 | 2016 | 104 | 0.510 |
Why?
|
| Antibodies, Bispecific | 1 | 2018 | 204 | 0.510 |
Why?
|
| Ubiquitin Thiolesterase | 1 | 2019 | 462 | 0.510 |
Why?
|
| Crystallography, X-Ray | 5 | 2024 | 1956 | 0.510 |
Why?
|
| Glycoproteins | 3 | 2023 | 2204 | 0.500 |
Why?
|
| Drug Delivery Systems | 4 | 2023 | 2236 | 0.500 |
Why?
|
| Pancreatitis | 1 | 2022 | 1087 | 0.500 |
Why?
|
| Neoplasms | 8 | 2024 | 22389 | 0.490 |
Why?
|
| Viral Load | 5 | 2021 | 3398 | 0.490 |
Why?
|
| HIV Core Protein p24 | 1 | 2015 | 247 | 0.490 |
Why?
|
| Leukocytes, Mononuclear | 2 | 2019 | 1855 | 0.490 |
Why?
|
| Chemistry Techniques, Analytical | 1 | 2015 | 49 | 0.490 |
Why?
|
| Body Weight | 3 | 2022 | 4630 | 0.490 |
Why?
|
| Proto-Oncogene Proteins c-met | 1 | 2019 | 567 | 0.480 |
Why?
|
| Cytological Techniques | 1 | 2017 | 218 | 0.480 |
Why?
|
| Adenine | 1 | 2021 | 993 | 0.480 |
Why?
|
| Swine | 6 | 2024 | 5993 | 0.480 |
Why?
|
| Hemagglutination Inhibition Tests | 4 | 2019 | 87 | 0.470 |
Why?
|
| Protein Multimerization | 5 | 2024 | 972 | 0.470 |
Why?
|
| Immunoconjugates | 1 | 2022 | 969 | 0.470 |
Why?
|
| Drug Design | 2 | 2020 | 1046 | 0.470 |
Why?
|
| Amino Acid Sequence | 13 | 2023 | 13425 | 0.470 |
Why?
|
| Antigens, Neoplasm | 4 | 2020 | 1999 | 0.460 |
Why?
|
| Animals, Newborn | 6 | 2021 | 2695 | 0.460 |
Why?
|
| Male | 54 | 2023 | 364870 | 0.460 |
Why?
|
| Swine, Miniature | 1 | 2016 | 965 | 0.460 |
Why?
|
| Dexamethasone | 1 | 2022 | 1965 | 0.460 |
Why?
|
| Receptors, Fc | 1 | 2018 | 538 | 0.450 |
Why?
|
| Liver | 5 | 2023 | 7570 | 0.450 |
Why?
|
| Vero Cells | 3 | 2021 | 486 | 0.450 |
Why?
|
| Vaccines, Inactivated | 3 | 2022 | 185 | 0.450 |
Why?
|
| Cricetulus | 3 | 2022 | 813 | 0.450 |
Why?
|
| Cholera Toxin | 1 | 2016 | 562 | 0.450 |
Why?
|
| Molecular Biology | 1 | 2017 | 573 | 0.440 |
Why?
|
| Young Adult | 26 | 2023 | 60048 | 0.430 |
Why?
|
| DNA, Complementary | 2 | 2015 | 1992 | 0.430 |
Why?
|
| DNA | 3 | 2023 | 7211 | 0.430 |
Why?
|
| Sex Characteristics | 2 | 2021 | 2661 | 0.430 |
Why?
|
| Serpins | 2 | 2005 | 245 | 0.430 |
Why?
|
| Spodoptera | 5 | 2020 | 141 | 0.430 |
Why?
|
| Viruses | 1 | 2016 | 373 | 0.410 |
Why?
|
| Gene Transfer Techniques | 3 | 2016 | 1209 | 0.410 |
Why?
|
| Adult | 40 | 2024 | 223622 | 0.400 |
Why?
|
| Diagnostic Tests, Routine | 2 | 2016 | 790 | 0.400 |
Why?
|
| Alanine Transaminase | 5 | 2022 | 604 | 0.400 |
Why?
|
| Awards and Prizes | 1 | 2016 | 365 | 0.400 |
Why?
|
| Molecular Sequence Data | 11 | 2015 | 17626 | 0.400 |
Why?
|
| Antigens, Bacterial | 1 | 2017 | 1150 | 0.400 |
Why?
|
| Research | 1 | 2020 | 1981 | 0.400 |
Why?
|
| Anti-Inflammatory Agents | 1 | 2022 | 1812 | 0.390 |
Why?
|
| Hybridomas | 3 | 2022 | 444 | 0.390 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 2 | 2021 | 4584 | 0.390 |
Why?
|
| Interleukin-6 | 2 | 2022 | 3230 | 0.380 |
Why?
|
| Parkinson Disease | 2 | 2023 | 2893 | 0.380 |
Why?
|
| Organic Anion Transporters, Sodium-Dependent | 4 | 2024 | 26 | 0.380 |
Why?
|
| Blotting, Western | 8 | 2019 | 5033 | 0.380 |
Why?
|
| Histocompatibility Antigens Class I | 1 | 2018 | 1362 | 0.370 |
Why?
|
| Point-of-Care Systems | 3 | 2017 | 1238 | 0.370 |
Why?
|
| Protein Precursors | 3 | 2024 | 1134 | 0.370 |
Why?
|
| Serologic Tests | 5 | 2020 | 383 | 0.360 |
Why?
|
| Sequence Deletion | 5 | 2024 | 1496 | 0.360 |
Why?
|
| RNA Interference | 4 | 2017 | 2836 | 0.360 |
Why?
|
| Carrier State | 3 | 2015 | 529 | 0.360 |
Why?
|
| Mutation | 15 | 2023 | 30230 | 0.350 |
Why?
|
| Feces | 4 | 2023 | 1516 | 0.350 |
Why?
|
| NF-kappa B | 3 | 2018 | 2487 | 0.350 |
Why?
|
| Mice, Nude | 3 | 2023 | 3630 | 0.350 |
Why?
|
| Poultry Diseases | 1 | 2010 | 24 | 0.350 |
Why?
|
| Virus Diseases | 1 | 2016 | 723 | 0.350 |
Why?
|
| Hepacivirus | 2 | 2016 | 1341 | 0.340 |
Why?
|
| Adolescent | 22 | 2022 | 89182 | 0.340 |
Why?
|
| Biomimetic Materials | 1 | 2011 | 173 | 0.340 |
Why?
|
| Virology | 1 | 2010 | 76 | 0.340 |
Why?
|
| Cross Reactions | 3 | 2018 | 828 | 0.340 |
Why?
|
| Pregnancy Complications, Infectious | 1 | 2022 | 2185 | 0.340 |
Why?
|
| Immunoglobulin Fab Fragments | 2 | 2024 | 446 | 0.330 |
Why?
|
| Gene Expression Regulation, Viral | 6 | 2021 | 435 | 0.330 |
Why?
|
| Tumor Microenvironment | 5 | 2024 | 3940 | 0.330 |
Why?
|
| Hemagglutinins, Viral | 1 | 2009 | 66 | 0.330 |
Why?
|
| Ferrets | 2 | 2022 | 181 | 0.330 |
Why?
|
| Amino Acid Motifs | 3 | 2021 | 928 | 0.330 |
Why?
|
| Molecular Diagnostic Techniques | 1 | 2014 | 620 | 0.330 |
Why?
|
| Luminescent Proteins | 3 | 2016 | 839 | 0.330 |
Why?
|
| Skin | 3 | 2022 | 4499 | 0.320 |
Why?
|
| Mice, Transgenic | 6 | 2023 | 9563 | 0.320 |
Why?
|
| Microscopy, Electron, Transmission | 3 | 2018 | 691 | 0.320 |
Why?
|
| Fermentation | 1 | 2009 | 142 | 0.320 |
Why?
|
| Conserved Sequence | 3 | 2022 | 1163 | 0.310 |
Why?
|
| CHO Cells | 3 | 2021 | 1380 | 0.310 |
Why?
|
| Virus Shedding | 3 | 2018 | 110 | 0.300 |
Why?
|
| HEK293 Cells | 6 | 2024 | 4286 | 0.300 |
Why?
|
| Biological Products | 3 | 2017 | 934 | 0.300 |
Why?
|
| Symporters | 4 | 2024 | 363 | 0.300 |
Why?
|
| Host-Pathogen Interactions | 5 | 2016 | 1468 | 0.300 |
Why?
|
| Acquired Immunodeficiency Syndrome | 1 | 2016 | 2202 | 0.290 |
Why?
|
| Protein Interaction Domains and Motifs | 2 | 2021 | 450 | 0.290 |
Why?
|
| Electrophoresis, Polyacrylamide Gel | 6 | 2016 | 1732 | 0.290 |
Why?
|
| Temperature | 4 | 2021 | 2234 | 0.280 |
Why?
|
| Induced Pluripotent Stem Cells | 1 | 2019 | 1889 | 0.280 |
Why?
|
| Reagent Kits, Diagnostic | 2 | 2010 | 239 | 0.280 |
Why?
|
| Middle Aged | 28 | 2023 | 223463 | 0.280 |
Why?
|
| Immunoglobulin Variable Region | 2 | 2006 | 420 | 0.280 |
Why?
|
| Horseradish Peroxidase | 2 | 2018 | 170 | 0.270 |
Why?
|
| Genes, Viral | 3 | 2023 | 655 | 0.270 |
Why?
|
| Transcription Factor AP-1 | 2 | 2018 | 321 | 0.270 |
Why?
|
| Heat-Shock Proteins | 1 | 2010 | 797 | 0.270 |
Why?
|
| Limit of Detection | 2 | 2018 | 276 | 0.270 |
Why?
|
| Escherichia coli Proteins | 3 | 2022 | 1057 | 0.260 |
Why?
|
| Hepatitis C | 1 | 2016 | 1593 | 0.260 |
Why?
|
| Aluminum | 2 | 2023 | 150 | 0.260 |
Why?
|
| ROC Curve | 3 | 2019 | 3622 | 0.260 |
Why?
|
| Immunity | 2 | 2022 | 1003 | 0.260 |
Why?
|
| Oligopeptides | 1 | 2011 | 1194 | 0.260 |
Why?
|
| Combined Modality Therapy | 4 | 2024 | 8562 | 0.260 |
Why?
|
| Mice, Inbred C57BL | 10 | 2024 | 22355 | 0.250 |
Why?
|
| Anus Neoplasms | 2 | 2019 | 337 | 0.240 |
Why?
|
| Amino Acid Substitution | 3 | 2018 | 1743 | 0.240 |
Why?
|
| Time Factors | 10 | 2020 | 40267 | 0.240 |
Why?
|
| Genetic Engineering | 3 | 2021 | 936 | 0.240 |
Why?
|
| Dogs | 3 | 2019 | 3846 | 0.240 |
Why?
|
| Cell Proliferation | 3 | 2021 | 10464 | 0.240 |
Why?
|
| Double-Blind Method | 4 | 2022 | 12457 | 0.240 |
Why?
|
| Antibody Affinity | 2 | 2016 | 253 | 0.240 |
Why?
|
| Treatment Outcome | 11 | 2022 | 65365 | 0.240 |
Why?
|
| Tuberculosis | 1 | 2017 | 2029 | 0.240 |
Why?
|
| Models, Animal | 4 | 2020 | 2124 | 0.230 |
Why?
|
| Virulence | 3 | 2023 | 1298 | 0.230 |
Why?
|
| Receptors, Scavenger | 1 | 2024 | 123 | 0.230 |
Why?
|
| Fluorescence | 3 | 2024 | 760 | 0.230 |
Why?
|
| Protein Transport | 3 | 2021 | 1958 | 0.230 |
Why?
|
| Prevalence | 7 | 2021 | 15868 | 0.230 |
Why?
|
| Hematopoietic Stem Cell Transplantation | 1 | 2022 | 5711 | 0.230 |
Why?
|
| Sequence Analysis, DNA | 5 | 2020 | 4774 | 0.230 |
Why?
|
| Adjuvants, Pharmaceutic | 1 | 2024 | 48 | 0.230 |
Why?
|
| Membrane Glycoproteins | 3 | 2023 | 3712 | 0.220 |
Why?
|
| Rotenone | 1 | 2023 | 50 | 0.220 |
Why?
|
| Physalis | 1 | 2003 | 1 | 0.220 |
Why?
|
| HIV Infections | 5 | 2022 | 17575 | 0.220 |
Why?
|
| Aged | 19 | 2023 | 171544 | 0.220 |
Why?
|
| CD4-CD8 Ratio | 1 | 2023 | 114 | 0.220 |
Why?
|
| Computer Simulation | 1 | 2017 | 6277 | 0.220 |
Why?
|
| Phagocytosis | 2 | 2022 | 1530 | 0.220 |
Why?
|
| Lab-On-A-Chip Devices | 2 | 2018 | 446 | 0.210 |
Why?
|
| Sigmodontinae | 1 | 2022 | 8 | 0.210 |
Why?
|
| Fluorescent Antibody Technique | 2 | 2019 | 2474 | 0.210 |
Why?
|
| Immune Evasion | 3 | 2024 | 376 | 0.210 |
Why?
|
| Cell Survival | 4 | 2024 | 5792 | 0.210 |
Why?
|
| CD4 Lymphocyte Count | 3 | 2018 | 2596 | 0.210 |
Why?
|
| Binding Sites, Antibody | 2 | 2015 | 340 | 0.210 |
Why?
|
| Antigens, Heterophile | 1 | 2023 | 70 | 0.210 |
Why?
|
| Hydrogen Bonding | 2 | 2015 | 290 | 0.210 |
Why?
|
| Ultrasonics | 1 | 2023 | 208 | 0.210 |
Why?
|
| Viral Structures | 1 | 2022 | 1 | 0.200 |
Why?
|
| Durapatite | 1 | 2024 | 166 | 0.200 |
Why?
|
| 5' Untranslated Regions | 2 | 2021 | 255 | 0.200 |
Why?
|
| Immune Sera | 2 | 2016 | 605 | 0.200 |
Why?
|
| Herpesvirus 1, Cercopithecine | 1 | 2022 | 2 | 0.200 |
Why?
|
| Culture Media | 2 | 2020 | 898 | 0.200 |
Why?
|
| Flow Cytometry | 5 | 2016 | 5898 | 0.200 |
Why?
|
| Tropism | 1 | 2022 | 44 | 0.200 |
Why?
|
| Microscopy, Electron | 3 | 2017 | 2559 | 0.200 |
Why?
|
| Immunity, Innate | 4 | 2023 | 3079 | 0.200 |
Why?
|
| Urine | 2 | 2021 | 363 | 0.200 |
Why?
|
| Hemagglutinins | 1 | 2022 | 111 | 0.200 |
Why?
|
| Child, Preschool | 7 | 2022 | 42654 | 0.200 |
Why?
|
| Biomedical Research | 2 | 2019 | 3464 | 0.200 |
Why?
|
| Asymptomatic Infections | 1 | 2022 | 135 | 0.190 |
Why?
|
| Nucleic Acid Amplification Techniques | 2 | 2015 | 339 | 0.190 |
Why?
|
| Point Mutation | 4 | 2021 | 1595 | 0.190 |
Why?
|
| Incidence | 5 | 2022 | 21544 | 0.190 |
Why?
|
| Aborted Fetus | 1 | 2021 | 11 | 0.190 |
Why?
|
| Mutant Proteins | 2 | 2018 | 489 | 0.190 |
Why?
|
| Infant | 6 | 2022 | 36512 | 0.190 |
Why?
|
| Epithelial Cells | 3 | 2021 | 3692 | 0.190 |
Why?
|
| Crystallization | 2 | 2020 | 523 | 0.190 |
Why?
|
| CD4-Positive T-Lymphocytes | 3 | 2023 | 4411 | 0.190 |
Why?
|
| Immunochemistry | 2 | 2018 | 116 | 0.190 |
Why?
|
| Models, Biological | 2 | 2018 | 9494 | 0.190 |
Why?
|
| Injections, Intraperitoneal | 1 | 2022 | 413 | 0.190 |
Why?
|
| Virus Uncoating | 1 | 2021 | 13 | 0.190 |
Why?
|
| Vulva | 2 | 2019 | 84 | 0.180 |
Why?
|
| Hydrogen-Ion Concentration | 2 | 2021 | 2487 | 0.180 |
Why?
|
| Biosynthetic Pathways | 1 | 2021 | 138 | 0.180 |
Why?
|
| Formaldehyde | 1 | 2022 | 361 | 0.180 |
Why?
|
| Immunocompetence | 2 | 2018 | 138 | 0.180 |
Why?
|
| Vesicular stomatitis Indiana virus | 1 | 2020 | 93 | 0.180 |
Why?
|
| Melanoma, Experimental | 1 | 2024 | 559 | 0.180 |
Why?
|
| Drug Storage | 2 | 2019 | 52 | 0.180 |
Why?
|
| Ribavirin | 1 | 2022 | 395 | 0.180 |
Why?
|
| Imidazoles | 2 | 2022 | 1168 | 0.180 |
Why?
|
| NF-E2-Related Factor 2 | 1 | 2023 | 378 | 0.180 |
Why?
|
| Edetic Acid | 1 | 2021 | 278 | 0.180 |
Why?
|
| Base Sequence | 5 | 2020 | 12421 | 0.180 |
Why?
|
| Cells, Cultured | 4 | 2021 | 19019 | 0.180 |
Why?
|
| Molecular Dynamics Simulation | 2 | 2016 | 428 | 0.180 |
Why?
|
| Freeze Drying | 1 | 2020 | 97 | 0.180 |
Why?
|
| Cellulose | 1 | 2020 | 118 | 0.180 |
Why?
|
| Infant, Newborn | 4 | 2023 | 26410 | 0.170 |
Why?
|
| Guinea Pigs | 1 | 2022 | 1309 | 0.170 |
Why?
|
| Penis | 2 | 2019 | 210 | 0.170 |
Why?
|
| DNA Mutational Analysis | 3 | 2018 | 4120 | 0.170 |
Why?
|
| Genes, Reporter | 2 | 2019 | 1524 | 0.170 |
Why?
|
| Viral Tropism | 2 | 2017 | 102 | 0.170 |
Why?
|
| Transformation, Genetic | 3 | 2004 | 194 | 0.170 |
Why?
|
| Thimerosal | 1 | 2019 | 15 | 0.170 |
Why?
|
| Cloning, Molecular | 3 | 2015 | 4168 | 0.170 |
Why?
|
| Pregnancy | 4 | 2023 | 30198 | 0.160 |
Why?
|
| Manganese Poisoning | 1 | 2019 | 13 | 0.160 |
Why?
|
| Nasal Cavity | 1 | 2021 | 311 | 0.160 |
Why?
|
| Lead Poisoning, Nervous System | 1 | 2019 | 12 | 0.160 |
Why?
|
| Iron-Regulatory Proteins | 1 | 2019 | 30 | 0.160 |
Why?
|
| Open Reading Frames | 1 | 2022 | 812 | 0.160 |
Why?
|
| Carbohydrates | 1 | 2021 | 389 | 0.160 |
Why?
|
| Azepines | 1 | 2021 | 329 | 0.160 |
Why?
|
| Quinuclidines | 1 | 2019 | 27 | 0.160 |
Why?
|
| Enterovirus D, Human | 1 | 2018 | 5 | 0.160 |
Why?
|
| Peptidyl-Dipeptidase A | 1 | 2020 | 326 | 0.160 |
Why?
|
| Child | 10 | 2023 | 80894 | 0.160 |
Why?
|
| Immunity, Cellular | 3 | 2022 | 1561 | 0.160 |
Why?
|
| Membrane Proteins | 1 | 2016 | 7885 | 0.160 |
Why?
|
| Promoter Regions, Genetic | 5 | 2021 | 5800 | 0.160 |
Why?
|
| Muscarinic Agonists | 1 | 2019 | 91 | 0.160 |
Why?
|
| Protein Engineering | 2 | 2018 | 550 | 0.160 |
Why?
|
| Reagent Strips | 1 | 2018 | 40 | 0.160 |
Why?
|
| Dose-Response Relationship, Immunologic | 1 | 2019 | 359 | 0.160 |
Why?
|
| Specific Pathogen-Free Organisms | 1 | 2018 | 220 | 0.160 |
Why?
|
| Microspheres | 1 | 2022 | 789 | 0.150 |
Why?
|
| Anal Canal | 2 | 2019 | 376 | 0.150 |
Why?
|
| Endosomes | 1 | 2021 | 525 | 0.150 |
Why?
|
| Calibration | 1 | 2021 | 823 | 0.150 |
Why?
|
| Pathology, Molecular | 1 | 2021 | 329 | 0.150 |
Why?
|
| Severity of Illness Index | 3 | 2022 | 15939 | 0.150 |
Why?
|
| B-Lymphocytes | 4 | 2022 | 4785 | 0.150 |
Why?
|
| Adsorption | 2 | 2016 | 197 | 0.150 |
Why?
|
| Immunity, Humoral | 2 | 2020 | 611 | 0.150 |
Why?
|
| Cohort Studies | 7 | 2023 | 41791 | 0.150 |
Why?
|
| trans-Golgi Network | 1 | 2017 | 33 | 0.150 |
Why?
|
| Mother-Child Relations | 1 | 2022 | 501 | 0.150 |
Why?
|
| Gene Order | 1 | 2018 | 167 | 0.150 |
Why?
|
| Protein Subunits | 1 | 2021 | 943 | 0.150 |
Why?
|
| Molecular Sequence Annotation | 1 | 2020 | 525 | 0.150 |
Why?
|
| Endonucleases | 1 | 2020 | 371 | 0.150 |
Why?
|
| bcl-X Protein | 1 | 2019 | 412 | 0.150 |
Why?
|
| Injections, Intramuscular | 1 | 2019 | 556 | 0.140 |
Why?
|
| Response Elements | 1 | 2019 | 308 | 0.140 |
Why?
|
| Nasopharynx | 1 | 2020 | 420 | 0.140 |
Why?
|
| MicroRNAs | 2 | 2017 | 3794 | 0.140 |
Why?
|
| Birds | 2 | 2009 | 166 | 0.140 |
Why?
|
| Oseltamivir | 1 | 2017 | 75 | 0.140 |
Why?
|
| Heterosexuality | 1 | 2019 | 309 | 0.140 |
Why?
|
| Tumor Necrosis Factor-alpha | 2 | 2022 | 4357 | 0.140 |
Why?
|
| Virus Activation | 1 | 2019 | 322 | 0.140 |
Why?
|
| Replicon | 1 | 2016 | 35 | 0.140 |
Why?
|
| Indocyanine Green | 1 | 2019 | 238 | 0.140 |
Why?
|
| Giant Cells | 1 | 2017 | 187 | 0.140 |
Why?
|
| Immunoprecipitation | 2 | 2017 | 874 | 0.140 |
Why?
|
| Particle Size | 2 | 2019 | 1653 | 0.140 |
Why?
|
| Algorithms | 1 | 2017 | 14154 | 0.140 |
Why?
|
| G1 Phase | 1 | 2018 | 402 | 0.140 |
Why?
|
| Cell Transplantation | 1 | 2019 | 474 | 0.140 |
Why?
|
| Tuberculin Test | 1 | 2017 | 205 | 0.140 |
Why?
|
| Publications | 1 | 2019 | 196 | 0.140 |
Why?
|
| Reproducibility of Results | 4 | 2023 | 20224 | 0.140 |
Why?
|
| Early Detection of Cancer | 2 | 2023 | 3236 | 0.140 |
Why?
|
| Goals | 1 | 2022 | 716 | 0.140 |
Why?
|
| TNF Receptor-Associated Death Domain Protein | 1 | 2016 | 5 | 0.140 |
Why?
|
| Immunohistochemistry | 2 | 2021 | 11117 | 0.140 |
Why?
|
| T-Lymphocytes | 2 | 2024 | 10266 | 0.140 |
Why?
|
| HeLa Cells | 3 | 2016 | 3092 | 0.130 |
Why?
|
| Nuclear Envelope | 1 | 2017 | 164 | 0.130 |
Why?
|
| Population Surveillance | 2 | 2018 | 2598 | 0.130 |
Why?
|
| Interleukin-10 | 1 | 2022 | 1184 | 0.130 |
Why?
|
| Calcium Phosphates | 1 | 2017 | 172 | 0.130 |
Why?
|
| Doxycycline | 1 | 2018 | 347 | 0.130 |
Why?
|
| Disease Susceptibility | 2 | 2021 | 1795 | 0.130 |
Why?
|
| Aspartate Aminotransferases | 1 | 2018 | 414 | 0.130 |
Why?
|
| Solvents | 1 | 2017 | 298 | 0.130 |
Why?
|
| Spectrometry, Fluorescence | 2 | 2015 | 694 | 0.130 |
Why?
|
| Ferritins | 1 | 2019 | 601 | 0.130 |
Why?
|
| Immunomodulation | 1 | 2020 | 549 | 0.130 |
Why?
|
| Surface Properties | 1 | 2019 | 1166 | 0.130 |
Why?
|
| Thymus Gland | 2 | 2023 | 1266 | 0.130 |
Why?
|
| Signal Transduction | 3 | 2018 | 23629 | 0.130 |
Why?
|
| Neuroblastoma | 1 | 2024 | 1265 | 0.130 |
Why?
|
| Drug Therapy | 1 | 2019 | 504 | 0.130 |
Why?
|
| Interferon-beta | 1 | 2018 | 349 | 0.130 |
Why?
|
| DNA Breaks, Double-Stranded | 1 | 2020 | 615 | 0.130 |
Why?
|
| Triazoles | 1 | 2021 | 904 | 0.130 |
Why?
|
| Bibliometrics | 1 | 2019 | 355 | 0.130 |
Why?
|
| Vagina | 2 | 2019 | 845 | 0.130 |
Why?
|
| Thermodynamics | 1 | 2017 | 590 | 0.130 |
Why?
|
| Culture Techniques | 1 | 2016 | 530 | 0.130 |
Why?
|
| Early Diagnosis | 1 | 2020 | 1195 | 0.120 |
Why?
|
| Cell Differentiation | 3 | 2024 | 11659 | 0.120 |
Why?
|
| Sequence Homology | 1 | 2015 | 199 | 0.120 |
Why?
|
| Transport Vesicles | 1 | 2015 | 81 | 0.120 |
Why?
|
| RNA, Messenger | 3 | 2020 | 12801 | 0.120 |
Why?
|
| Small Molecule Libraries | 1 | 2021 | 743 | 0.120 |
Why?
|
| Nuclear Pore Complex Proteins | 1 | 2016 | 164 | 0.120 |
Why?
|
| Serial Passage | 1 | 2014 | 23 | 0.120 |
Why?
|
| Hydrodynamics | 1 | 2016 | 168 | 0.120 |
Why?
|
| Protein Structure, Tertiary | 4 | 2023 | 3779 | 0.120 |
Why?
|
| Platelet Count | 1 | 2018 | 784 | 0.120 |
Why?
|
| Drug Discovery | 2 | 2021 | 1067 | 0.120 |
Why?
|
| Mice, Inbred C3H | 1 | 2016 | 915 | 0.120 |
Why?
|
| Xenograft Model Antitumor Assays | 2 | 2021 | 3616 | 0.120 |
Why?
|
| Virus Cultivation | 1 | 2014 | 88 | 0.120 |
Why?
|
| Hepatocyte Growth Factor | 1 | 2016 | 269 | 0.120 |
Why?
|
| Latent Tuberculosis | 1 | 2017 | 224 | 0.120 |
Why?
|
| Complementarity Determining Regions | 1 | 2015 | 150 | 0.120 |
Why?
|
| Microscopy, Fluorescence | 2 | 2019 | 2636 | 0.120 |
Why?
|
| Macaca | 1 | 2016 | 417 | 0.120 |
Why?
|
| Heparitin Sulfate | 1 | 2016 | 224 | 0.120 |
Why?
|
| Immunity, Maternally-Acquired | 1 | 2015 | 112 | 0.120 |
Why?
|
| Imaging, Three-Dimensional | 2 | 2018 | 4076 | 0.120 |
Why?
|
| Blood | 1 | 2017 | 597 | 0.120 |
Why?
|
| Thiophenes | 1 | 2019 | 569 | 0.120 |
Why?
|
| Likelihood Functions | 1 | 2017 | 993 | 0.120 |
Why?
|
| Photosensitizing Agents | 1 | 2019 | 631 | 0.120 |
Why?
|
| Microglia | 1 | 2023 | 1374 | 0.120 |
Why?
|
| Biological Transport | 1 | 2019 | 2086 | 0.120 |
Why?
|
| Nanostructures | 2 | 2018 | 553 | 0.120 |
Why?
|
| Chickens | 3 | 2014 | 845 | 0.110 |
Why?
|
| Lung Transplantation | 2 | 2021 | 1309 | 0.110 |
Why?
|
| Gene Expression Regulation, Bacterial | 1 | 2020 | 1137 | 0.110 |
Why?
|
| Cell Culture Techniques | 1 | 2021 | 1666 | 0.110 |
Why?
|
| Myositis | 1 | 2017 | 276 | 0.110 |
Why?
|
| Taiwan | 1 | 2015 | 528 | 0.110 |
Why?
|
| Lipopolysaccharides | 1 | 2021 | 2215 | 0.110 |
Why?
|
| Gene Targeting | 1 | 2017 | 841 | 0.110 |
Why?
|
| Apoptosis Regulatory Proteins | 1 | 2019 | 1151 | 0.110 |
Why?
|
| Transduction, Genetic | 1 | 2017 | 902 | 0.110 |
Why?
|
| Receptors, IgG | 1 | 2017 | 564 | 0.110 |
Why?
|
| Mutagenesis, Site-Directed | 3 | 2020 | 1684 | 0.110 |
Why?
|
| Sumoylation | 1 | 2014 | 83 | 0.110 |
Why?
|
| Inhibitory Concentration 50 | 1 | 2014 | 466 | 0.110 |
Why?
|
| Area Under Curve | 1 | 2018 | 1642 | 0.110 |
Why?
|
| Injections, Subcutaneous | 1 | 2015 | 687 | 0.110 |
Why?
|
| Plants, Genetically Modified | 2 | 2003 | 115 | 0.110 |
Why?
|
| Amyloid beta-Protein Precursor | 1 | 2019 | 1114 | 0.110 |
Why?
|
| Interferon-gamma | 1 | 2022 | 3164 | 0.110 |
Why?
|
| Prospective Studies | 6 | 2023 | 54921 | 0.110 |
Why?
|
| Mammals | 3 | 2022 | 1135 | 0.110 |
Why?
|
| Injections | 1 | 2016 | 840 | 0.110 |
Why?
|
| Ganglia, Spinal | 1 | 2016 | 530 | 0.110 |
Why?
|
| Disease Progression | 2 | 2021 | 13646 | 0.110 |
Why?
|
| Sequence Homology, Amino Acid | 2 | 2010 | 2750 | 0.110 |
Why?
|
| Antibodies, Bacterial | 1 | 2019 | 1478 | 0.100 |
Why?
|
| Inclusion Bodies | 2 | 2004 | 279 | 0.100 |
Why?
|
| Necrosis | 1 | 2017 | 1619 | 0.100 |
Why?
|
| Elasticity Imaging Techniques | 1 | 2018 | 395 | 0.100 |
Why?
|
| Uric Acid | 1 | 2019 | 806 | 0.100 |
Why?
|
| Gene Knockdown Techniques | 1 | 2017 | 1608 | 0.100 |
Why?
|
| Pregnancy Outcome | 1 | 2023 | 2961 | 0.100 |
Why?
|
| Acute Disease | 4 | 2019 | 7242 | 0.100 |
Why?
|
| Proto-Oncogene Proteins c-bcl-2 | 1 | 2019 | 1408 | 0.100 |
Why?
|
| Immunoblotting | 1 | 2016 | 1647 | 0.100 |
Why?
|
| Adenoviridae | 1 | 2017 | 1093 | 0.100 |
Why?
|
| RNA | 1 | 2022 | 2726 | 0.100 |
Why?
|
| Photochemotherapy | 1 | 2019 | 830 | 0.100 |
Why?
|
| Mercury | 1 | 2015 | 289 | 0.100 |
Why?
|
| Cell Adhesion Molecules | 1 | 2018 | 1614 | 0.100 |
Why?
|
| Software | 3 | 2017 | 4452 | 0.100 |
Why?
|
| Th1 Cells | 1 | 2017 | 1042 | 0.100 |
Why?
|
| Models, Genetic | 2 | 2017 | 3442 | 0.100 |
Why?
|
| Doxorubicin | 1 | 2019 | 2229 | 0.100 |
Why?
|
| Mesenchymal Stem Cells | 1 | 2023 | 1666 | 0.100 |
Why?
|
| Angiogenesis Inhibitors | 1 | 2022 | 2060 | 0.100 |
Why?
|
| Unfolded Protein Response | 1 | 2014 | 239 | 0.100 |
Why?
|
| Dimerization | 2 | 2004 | 886 | 0.100 |
Why?
|
| Th2 Cells | 1 | 2017 | 1078 | 0.100 |
Why?
|
| Cluster Analysis | 2 | 2015 | 2727 | 0.090 |
Why?
|
| Chick Embryo | 2 | 2014 | 975 | 0.090 |
Why?
|
| Disease Reservoirs | 2 | 2015 | 123 | 0.090 |
Why?
|
| Autoimmune Diseases | 1 | 2023 | 2257 | 0.090 |
Why?
|
| Sexual Behavior | 2 | 2019 | 2200 | 0.090 |
Why?
|
| Fibroblasts | 1 | 2022 | 4175 | 0.090 |
Why?
|
| Outpatients | 1 | 2019 | 1603 | 0.090 |
Why?
|
| Aged, 80 and over | 4 | 2019 | 59683 | 0.090 |
Why?
|
| Transforming Growth Factor beta1 | 1 | 2015 | 637 | 0.090 |
Why?
|
| Immunotherapy, Adoptive | 1 | 2021 | 1508 | 0.090 |
Why?
|
| DNA Repair | 1 | 2020 | 2050 | 0.090 |
Why?
|
| Tissue Donors | 1 | 2020 | 2389 | 0.090 |
Why?
|
| Central Nervous System | 1 | 2018 | 1346 | 0.090 |
Why?
|
| National Health Programs | 1 | 2014 | 442 | 0.090 |
Why?
|
| Staining and Labeling | 1 | 2014 | 1081 | 0.090 |
Why?
|
| Equipment Design | 2 | 2018 | 3529 | 0.090 |
Why?
|
| Killer Cells, Natural | 1 | 2019 | 2207 | 0.080 |
Why?
|
| Cell Cycle Proteins | 1 | 2021 | 3457 | 0.080 |
Why?
|
| Hepatitis Viruses | 1 | 2009 | 15 | 0.080 |
Why?
|
| Hemagglutination | 1 | 2009 | 32 | 0.080 |
Why?
|
| Maleates | 1 | 2009 | 18 | 0.080 |
Why?
|
| Goats | 1 | 2009 | 166 | 0.080 |
Why?
|
| Proteomics | 1 | 2023 | 3906 | 0.080 |
Why?
|
| Genetic Variation | 2 | 2020 | 6606 | 0.080 |
Why?
|
| Safety | 1 | 2014 | 1159 | 0.080 |
Why?
|
| Repressor Proteins | 1 | 2020 | 2986 | 0.080 |
Why?
|
| Calcium | 1 | 2022 | 5794 | 0.080 |
Why?
|
| Immunologic Memory | 1 | 2016 | 1374 | 0.080 |
Why?
|
| DNA Replication | 1 | 2016 | 1429 | 0.080 |
Why?
|
| Cell Membrane | 1 | 2018 | 3663 | 0.080 |
Why?
|
| Polystyrenes | 1 | 2009 | 105 | 0.080 |
Why?
|
| Health Personnel | 1 | 2022 | 3381 | 0.080 |
Why?
|
| Cardiomyopathy, Dilated | 1 | 2015 | 843 | 0.080 |
Why?
|
| Nucleic Acid Conformation | 1 | 2012 | 900 | 0.080 |
Why?
|
| Risk Factors | 6 | 2021 | 74954 | 0.080 |
Why?
|
| Enzyme Activation | 1 | 2014 | 3585 | 0.080 |
Why?
|
| Mass Screening | 3 | 2023 | 5451 | 0.080 |
Why?
|
| Rats | 2 | 2022 | 23833 | 0.080 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 2 | 2016 | 2889 | 0.070 |
Why?
|
| Recombination, Genetic | 1 | 2012 | 1526 | 0.070 |
Why?
|
| Drug Therapy, Combination | 1 | 2017 | 6319 | 0.070 |
Why?
|
| Regeneration | 1 | 2016 | 1525 | 0.070 |
Why?
|
| Molecular Targeted Therapy | 1 | 2019 | 2830 | 0.070 |
Why?
|
| Kidney Neoplasms | 1 | 2024 | 4301 | 0.070 |
Why?
|
| Glycosylation | 2 | 2022 | 1100 | 0.070 |
Why?
|
| DNA Shuffling | 1 | 2006 | 5 | 0.070 |
Why?
|
| Fluorescent Dyes | 1 | 2015 | 1926 | 0.070 |
Why?
|
| T-Lymphocyte Subsets | 1 | 2015 | 1813 | 0.070 |
Why?
|
| Sulfonamides | 1 | 2016 | 1980 | 0.070 |
Why?
|
| Mycobacterium tuberculosis | 1 | 2017 | 1931 | 0.070 |
Why?
|
| Anti-Infective Agents, Local | 1 | 2009 | 248 | 0.070 |
Why?
|
| Agricultural Workers' Diseases | 1 | 2006 | 28 | 0.070 |
Why?
|
| Blood Transfusion | 1 | 2013 | 1309 | 0.070 |
Why?
|
| Sex Factors | 2 | 2019 | 10656 | 0.070 |
Why?
|
| Swine Diseases | 1 | 2006 | 61 | 0.070 |
Why?
|
| Biopsy | 1 | 2018 | 6808 | 0.060 |
Why?
|
| Glioblastoma | 1 | 2021 | 3526 | 0.060 |
Why?
|
| Carrier Proteins | 1 | 2019 | 4940 | 0.060 |
Why?
|
| Nerve Tissue Proteins | 1 | 2018 | 4414 | 0.060 |
Why?
|
| Cytokines | 2 | 2017 | 7443 | 0.060 |
Why?
|
| Genomics | 1 | 2021 | 5916 | 0.060 |
Why?
|
| Administration, Oral | 2 | 2003 | 4043 | 0.060 |
Why?
|
| RNA, Small Interfering | 2 | 2014 | 3436 | 0.060 |
Why?
|
| Neurons | 2 | 2022 | 9512 | 0.060 |
Why?
|
| Genes, Immunoglobulin Light Chain | 1 | 2004 | 2 | 0.060 |
Why?
|
| Binding, Competitive | 1 | 2006 | 1142 | 0.060 |
Why?
|
| Protein Renaturation | 1 | 2004 | 10 | 0.060 |
Why?
|
| Clinical Trials as Topic | 2 | 2020 | 8051 | 0.060 |
Why?
|
| Sequence Analysis, RNA | 2 | 2020 | 2038 | 0.060 |
Why?
|
| Genes, Immunoglobulin Heavy Chain | 1 | 2004 | 58 | 0.060 |
Why?
|
| NAD+ Nucleosidase | 1 | 2024 | 43 | 0.060 |
Why?
|
| Transfection | 2 | 2020 | 5758 | 0.060 |
Why?
|
| Methanol | 1 | 2004 | 89 | 0.060 |
Why?
|
| Public Health | 1 | 2017 | 2681 | 0.060 |
Why?
|
| Sirtuin 2 | 1 | 2024 | 93 | 0.060 |
Why?
|
| Proto-Oncogene Proteins | 1 | 2016 | 4526 | 0.060 |
Why?
|
| Immunodominant Epitopes | 1 | 2025 | 244 | 0.060 |
Why?
|
| Kaplan-Meier Estimate | 1 | 2014 | 6541 | 0.060 |
Why?
|
| Colony Count, Microbial | 1 | 2004 | 328 | 0.050 |
Why?
|
| Bacteriological Techniques | 1 | 2004 | 276 | 0.050 |
Why?
|
| Transcription Factors | 2 | 2021 | 12166 | 0.050 |
Why?
|
| Virus Assembly | 1 | 2004 | 141 | 0.050 |
Why?
|
| Metals | 1 | 2007 | 713 | 0.050 |
Why?
|
| Uridine Diphosphate | 1 | 2022 | 35 | 0.050 |
Why?
|
| Phosphorylation | 1 | 2014 | 8326 | 0.050 |
Why?
|
| Valine | 1 | 2005 | 410 | 0.050 |
Why?
|
| Predictive Value of Tests | 2 | 2018 | 15455 | 0.050 |
Why?
|
| Gene Expression Regulation, Plant | 1 | 2003 | 211 | 0.050 |
Why?
|
| Haplorhini | 1 | 2003 | 524 | 0.050 |
Why?
|
| Bioreactors | 1 | 2004 | 246 | 0.050 |
Why?
|
| Immunoglobulin Fc Fragments | 1 | 2024 | 285 | 0.050 |
Why?
|
| NIH 3T3 Cells | 1 | 2004 | 669 | 0.050 |
Why?
|
| Cross-Sectional Studies | 1 | 2023 | 26373 | 0.050 |
Why?
|
| Diagnosis, Differential | 1 | 2017 | 13019 | 0.050 |
Why?
|
| Apoptosis | 1 | 2018 | 9506 | 0.050 |
Why?
|
| Prognosis | 1 | 2022 | 30020 | 0.050 |
Why?
|
| Mannans | 1 | 2021 | 58 | 0.050 |
Why?
|
| Survival Analysis | 1 | 2014 | 10117 | 0.050 |
Why?
|
| T-Lymphocytes, Regulatory | 1 | 2015 | 3111 | 0.050 |
Why?
|
| Age Factors | 1 | 2018 | 18472 | 0.050 |
Why?
|
| Membrane Fusion | 1 | 2022 | 265 | 0.050 |
Why?
|
| Phenotype | 2 | 2012 | 16716 | 0.050 |
Why?
|
| Herpesvirus 2, Human | 1 | 2022 | 191 | 0.040 |
Why?
|
| Models, Statistical | 1 | 2015 | 5099 | 0.040 |
Why?
|
| Immunization, Secondary | 1 | 2003 | 372 | 0.040 |
Why?
|
| Codon, Nonsense | 1 | 2022 | 287 | 0.040 |
Why?
|
| beta-Glucans | 1 | 2021 | 129 | 0.040 |
Why?
|
| Mutation, Missense | 1 | 2009 | 2593 | 0.040 |
Why?
|
| Lac Operon | 1 | 2020 | 237 | 0.040 |
Why?
|
| NAD | 1 | 2024 | 618 | 0.040 |
Why?
|
| Protein Kinase Inhibitors | 1 | 2016 | 5707 | 0.040 |
Why?
|
| Chitosan | 1 | 2021 | 140 | 0.040 |
Why?
|
| Polyethylene Glycols | 2 | 2016 | 1195 | 0.040 |
Why?
|
| Brain Neoplasms | 1 | 2021 | 9197 | 0.040 |
Why?
|
| Nuclear Proteins | 1 | 2014 | 5802 | 0.040 |
Why?
|
| Genitalia, Male | 1 | 2019 | 87 | 0.040 |
Why?
|
| Histocompatibility Antigens Class II | 1 | 2023 | 1438 | 0.040 |
Why?
|
| Viral Matrix Proteins | 1 | 2020 | 193 | 0.040 |
Why?
|
| Drug Stability | 1 | 2019 | 291 | 0.040 |
Why?
|
| Risk Assessment | 2 | 2018 | 24316 | 0.040 |
Why?
|
| Glutamic Acid | 1 | 2005 | 1193 | 0.040 |
Why?
|
| Immobilized Proteins | 1 | 2018 | 24 | 0.040 |
Why?
|
| Kinetics | 2 | 2017 | 6334 | 0.040 |
Why?
|
| Lymphocyte Activation | 2 | 2023 | 5496 | 0.040 |
Why?
|
| Genitalia, Female | 1 | 2019 | 146 | 0.040 |
Why?
|
| Surface Plasmon Resonance | 1 | 2018 | 272 | 0.040 |
Why?
|
| Immunoglobulin E | 1 | 2004 | 1507 | 0.040 |
Why?
|
| Mice, Inbred ICR | 1 | 2018 | 363 | 0.040 |
Why?
|
| Biomimetics | 1 | 2018 | 172 | 0.030 |
Why?
|
| Parietal Lobe | 1 | 2022 | 866 | 0.030 |
Why?
|
| Cell Fusion | 1 | 2017 | 294 | 0.030 |
Why?
|
| DNA-Binding Proteins | 1 | 2014 | 9618 | 0.030 |
Why?
|
| Calorimetry, Differential Scanning | 1 | 2016 | 97 | 0.030 |
Why?
|
| Olfactory Bulb | 1 | 2018 | 198 | 0.030 |
Why?
|
| RNA, Untranslated | 1 | 2020 | 457 | 0.030 |
Why?
|
| Octoxynol | 1 | 2016 | 76 | 0.030 |
Why?
|
| Antigen Presentation | 1 | 2022 | 1251 | 0.030 |
Why?
|
| Paralysis | 1 | 2018 | 250 | 0.030 |
Why?
|
| Antineoplastic Agents | 1 | 2019 | 13696 | 0.030 |
Why?
|
| Toll-Like Receptor 3 | 1 | 2016 | 99 | 0.030 |
Why?
|
| Immune Tolerance | 2 | 2015 | 2324 | 0.030 |
Why?
|
| Autoimmunity | 1 | 2023 | 1360 | 0.030 |
Why?
|
| Nanomedicine | 1 | 2018 | 292 | 0.030 |
Why?
|
| Lymphocyte Cooperation | 1 | 2015 | 112 | 0.030 |
Why?
|
| Influenza A Virus, H7N1 Subtype | 1 | 2014 | 1 | 0.030 |
Why?
|
| Retrospective Studies | 3 | 2023 | 81768 | 0.030 |
Why?
|
| Influenza A Virus, H9N2 Subtype | 1 | 2014 | 8 | 0.030 |
Why?
|
| Surface-Active Agents | 1 | 2015 | 152 | 0.030 |
Why?
|
| Genome, Bacterial | 1 | 2020 | 796 | 0.030 |
Why?
|
| Cations, Divalent | 1 | 2015 | 167 | 0.030 |
Why?
|
| Chemical Phenomena | 1 | 2015 | 486 | 0.030 |
Why?
|
| Receptors, Antigen, T-Cell | 1 | 2023 | 2568 | 0.030 |
Why?
|
| Influenza A Virus, H3N2 Subtype | 1 | 2014 | 85 | 0.030 |
Why?
|
| Testis | 1 | 2018 | 783 | 0.030 |
Why?
|
| Virus Physiological Phenomena | 1 | 2014 | 15 | 0.030 |
Why?
|
| Zoonoses | 1 | 2015 | 180 | 0.030 |
Why?
|
| Small Ubiquitin-Related Modifier Proteins | 1 | 2014 | 68 | 0.030 |
Why?
|
| Sequence Analysis | 1 | 2014 | 240 | 0.030 |
Why?
|
| Gene Expression Regulation | 2 | 2016 | 11914 | 0.030 |
Why?
|
| Host Specificity | 1 | 2014 | 56 | 0.030 |
Why?
|
| Canada | 1 | 2019 | 2139 | 0.030 |
Why?
|
| HIV Seropositivity | 1 | 2019 | 962 | 0.030 |
Why?
|
| Follow-Up Studies | 1 | 2015 | 39405 | 0.030 |
Why?
|
| Gene Deletion | 1 | 2021 | 2673 | 0.030 |
Why?
|
| Saliva | 1 | 2018 | 854 | 0.030 |
Why?
|
| Anti-HIV Agents | 1 | 2009 | 4571 | 0.030 |
Why?
|
| Cold Temperature | 1 | 2016 | 786 | 0.030 |
Why?
|
| Regenerative Medicine | 1 | 2016 | 311 | 0.030 |
Why?
|
| Phosphatidylinositol 3-Kinases | 1 | 2022 | 2884 | 0.030 |
Why?
|
| Universities | 1 | 2018 | 1005 | 0.030 |
Why?
|
| Microscopy, Confocal | 1 | 2018 | 1972 | 0.030 |
Why?
|
| Acetaminophen | 1 | 2016 | 556 | 0.020 |
Why?
|
| Heterozygote | 1 | 2019 | 2792 | 0.020 |
Why?
|
| Molecular Weight | 1 | 2014 | 2172 | 0.020 |
Why?
|
| Phospholipids | 1 | 2015 | 783 | 0.020 |
Why?
|
| Case-Control Studies | 2 | 2023 | 22292 | 0.020 |
Why?
|
| Protein Biosynthesis | 1 | 2019 | 2094 | 0.020 |
Why?
|
| Ubiquitination | 1 | 2016 | 1011 | 0.020 |
Why?
|
| Bacterial Proteins | 1 | 2024 | 3835 | 0.020 |
Why?
|
| Severe Acute Respiratory Syndrome | 1 | 2012 | 136 | 0.020 |
Why?
|
| Down Syndrome | 1 | 2019 | 915 | 0.020 |
Why?
|
| Neoplasm Metastasis | 1 | 2021 | 4921 | 0.020 |
Why?
|
| Transgenes | 1 | 2014 | 1015 | 0.020 |
Why?
|
| Image Processing, Computer-Assisted | 2 | 2018 | 9063 | 0.020 |
Why?
|
| Ligands | 1 | 2017 | 3283 | 0.020 |
Why?
|
| Iron | 1 | 2019 | 1815 | 0.020 |
Why?
|
| Endothelial Cells | 1 | 2023 | 3587 | 0.020 |
Why?
|
| Nanotechnology | 1 | 2015 | 714 | 0.020 |
Why?
|
| Lysine | 1 | 2014 | 988 | 0.020 |
Why?
|
| National Institutes of Health (U.S.) | 1 | 2013 | 794 | 0.020 |
Why?
|
| Cell Movement | 1 | 2021 | 5214 | 0.020 |
Why?
|
| Transplantation, Heterologous | 1 | 2017 | 2394 | 0.020 |
Why?
|
| Feasibility Studies | 1 | 2019 | 5311 | 0.020 |
Why?
|
| Students | 1 | 2018 | 1744 | 0.020 |
Why?
|
| Colitis | 1 | 2016 | 1244 | 0.020 |
Why?
|
| Adaptation, Physiological | 1 | 2014 | 1315 | 0.020 |
Why?
|
| Epigenesis, Genetic | 1 | 2021 | 3826 | 0.020 |
Why?
|
| Transforming Growth Factor beta | 1 | 2015 | 2003 | 0.020 |
Why?
|
| Natriuretic Peptide, Brain | 1 | 2015 | 1751 | 0.020 |
Why?
|
| Up-Regulation | 1 | 2015 | 4137 | 0.020 |
Why?
|
| Gene Expression Profiling | 1 | 2021 | 9508 | 0.020 |
Why?
|
| Hippocampus | 1 | 2018 | 3784 | 0.020 |
Why?
|
| Gene Expression Regulation, Neoplastic | 1 | 2021 | 8628 | 0.020 |
Why?
|
| Cognition | 1 | 2022 | 7074 | 0.010 |
Why?
|
| Cost-Benefit Analysis | 1 | 2017 | 5538 | 0.010 |
Why?
|
| Transcription, Genetic | 1 | 2016 | 7599 | 0.010 |
Why?
|
| Ultrasonography | 1 | 2015 | 6001 | 0.010 |
Why?
|
| Cerebral Cortex | 1 | 2018 | 5830 | 0.010 |
Why?
|
| Longitudinal Studies | 1 | 2018 | 14783 | 0.010 |
Why?
|
| Stroke Volume | 1 | 2015 | 5620 | 0.010 |
Why?
|
| United States | 2 | 2019 | 73144 | 0.010 |
Why?
|
| Alzheimer Disease | 1 | 2019 | 8747 | 0.010 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2019 | 18047 | 0.010 |
Why?
|
| Registries | 1 | 2013 | 8378 | 0.010 |
Why?
|
| Brain | 1 | 2018 | 27452 | 0.010 |
Why?
|